Orphenadrine Citrate
Product Images NDC 21695-099

2 FDA label images from Rebel Distributors Corp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Orphenadrine Citrate (NDC 21695-099). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Orphenadrine Citrate Chemical Structure (34769dda F555 460e 9064 98ab205393c5 01)

Orphenadrine Citrate Chemical Structure (34769dda F555 460e 9064 98ab205393c5 01)
Chemical structure of Orphenadrine Citrate, showing the molecular components of the active ingredient and citrate moiety as depicted in the diagram.*
FDA Label Image

Orphenadrine Citrate 100mg (34769dda F555 460e 9064 98ab205393c5 02)

Orphenadrine Citrate 100mg (34769dda F555 460e 9064 98ab205393c5 02)
Label for Orphenadrine Citrate 100mg Extended Release Tablets, quantity 30, by Rebel Distributors Corp. The label includes dosing information stating each tablet contains 100mg Orphenadrine citrate, with physical description of the tablets as round, white to off-white, debossed 'NL4' on one side. Manufacturer is listed as Novel Laboratories, Inc., Somerset, NJ. Storage instructions and a website for Physician Partner are also shown.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.